ScholarIQanswers from OpenAlex
The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients
PaperCitations, authors & open-access status
The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 237 citations, 2016 year and diamond oa status.
237
Citations
2016
Year
diamond
OA Status